Deciphering Acetaminophen-Induced Hepatotoxicity: The Crucial Role of Transcription Factors like Nuclear Factor Erythroid 2-Related Factor 2 (NRF2) as Genetic Determinants of Susceptibility to Drug-Induced Liver Injury
Drug Metabolism and Disposition,
Journal Year:
2024,
Volume and Issue:
52(8), P. 740 - 753
Published: June 10, 2024
Acetaminophen
(APAP)
is
the
most
commonly
used
over-the-counter
medication
throughout
world.
At
therapeutic
doses,
APAP
has
potent
analgesic
and
antipyretic
effects.
The
efficacy
safety
of
are
influenced
by
multifactorial
processes
dependent
upon
dosing,
namely
frequency
total
dose.
poisoning
repeated
ingestion
supratherapeutic
depletes
glutathione
stores
in
liver
other
organs
capable
metabolic
bioactivation,
leading
to
hepatocellular
death
due
exhausted
antioxidant
defenses.
Numerous
genes,
encompassing
transcription
factors
signaling
pathways,
have
been
identified
as
playing
pivotal
roles
toxicity,
with
being
primary
organ
studied
its
central
role
metabolism
injury.
Nuclear
factor
erythroid
2-related
2
(NRF2)
array
downstream
responsive
genes
crucial
counteracting
toxicity.
NRF2,
along
negative
regulator
Kelch-like
ECH-associated
protein
1,
plays
a
vital
regulating
intracellular
redox
homeostasis.
This
regulation
significant
modulating
oxidative
stress,
inflammation,
induced
APAP.
In
this
review,
we
provide
an
updated
overview
mechanisms
through
which
NRF2
activation
critically
influence
threshold
for
developing
We
also
describe
how
genetically
modified
rodent
models
related
underscoring
significance
response
pathway.
While
focus,
article
comprehensively
explores
genetic
involved
phase
I
II
APAP,
pathways
that
contribute
thereby
providing
holistic
understanding
landscape
influencing
susceptibility
condition.
SIGNIFICANCE
STATEMENT:
review
summarizes
elements
underlying
APAP-induced
focusing
on
protective
NRF2.
delves
into
intricacies
potential
harm.
It
emphasizes
need
deeper
insight
molecular
hepatotoxicity,
especially
interplay
pathways.
Language: Английский
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
Nikitha Naomi Dsouza,
No information about this author
Varun Alampady,
No information about this author
Krishnaprasad Baby
No information about this author
et al.
Inflammopharmacology,
Journal Year:
2023,
Volume and Issue:
31(3), P. 1167 - 1182
Published: March 25, 2023
Abstract
The
“Thalidomide
tragedy”
is
a
landmark
in
the
history
of
pharmaceutical
industry.
Despite
limited
clinical
trials,
there
continuous
effort
to
investigate
thalidomide
as
drug
for
cancer
and
inflammatory
diseases
such
rheumatoid
arthritis,
lepromatous
leprosy,
COVID-19.
This
review
focuses
on
possibilities
targeting
inflammation
by
repurposing
treatment
idiopathic
pulmonary
fibrosis
(IPF).
Articles
were
searched
from
Scopus
database,
sorted,
selected
articles
reviewed.
content
includes
proven
mechanisms
action
relevant
IPF.
Inflammation,
oxidative
stress,
epigenetic
are
major
pathogenic
factors
Transforming
growth
factor-β
(TGF-β)
biomarker
Thalidomide
an
effective
anti-inflammatory
inhibiting
TGF-β,
interleukins
(IL-6
IL-1β),
tumour
necrosis
factor-α
(TNF-α).
binds
cereblon,
process
that
involved
proposed
mechanism
specific
cancers
breast
cancer,
colon
multiple
myeloma,
lung
cancer.
Cereblon
activating
AMP-activated
protein
kinase
(AMPK)-TGF-β/Smad
signalling,
thereby
attenuating
fibrosis.
past
few
years
have
witnessed
improvement
identification
biomarkers
diagnostic
technologies
respiratory
diseases,
partly
because
COVID-19
pandemic.
Hence,
investment
trials
with
systematic
plan
can
help
repurpose
Graphical
Language: Английский
Identification of natural Rutaecarpine as a potent tobacco mosaic virus (TMV) helicase candidate for managing intractable plant viral diseases
Zhenxing Li,
No information about this author
Jinhong Hu,
No information about this author
Rong‐Shuang Luo
No information about this author
et al.
Pest Management Science,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 5, 2023
Abstract
BACKGROUND
Naturally
occurring
alkaloids
are
particularly
suitable
for
use
as
pesticide
precursors
and
further
modifications
due
to
their
cost‐effectiveness,
unique
mechanism
of
action,
tolerable
degradation,
environmental
friendliness.
The
famous
tobacco
mosaic
virus
(TMV)
is
a
persistent
plant
pathogenic
that
can
parasitize
many
plants
severely
reduce
crop
production.
To
treat
TMV
disease,
helicase
acts
crucial
target
by
hydrolyzing
adenosine
triphosphate
(ATP)
provide
energy
double‐stranded
RNA
unwinding.
RESULTS
seek
novel
framework
alkaloid
leads
targeting
helicase,
this
work
successfully
established
an
efficient
screening
platform
inhibitors
based
on
natural
alkaloids.
In
vivo
activity
screening,
enzyme
detection,
binding
assays
showed
Rutaecarpine
from
Evodia
rutaecarpa
(Juss.)
Benth
exhibited
excellent
inhibitory
properties
[dissociation
constant
(
K
d
)
=
1.1
μ
m
,
half
maximal
concentration
(IC
50
227.24
]
anti‐TMV
ability.
Molecular
docking
dynamic
simulations
depicted
could
stably
bind
in
active
pockets
with
low
(Δ
G
−17.8
kcal/mol)
driven
hydrogen
bonding
hydrophobic
interactions.
CONCLUSION
Given
Rutaecarpine's
laudable
bioactivity
structural
modifiability,
it
serve
privileged
building
block
discovery.
Language: Английский
Investigation of the relationship between ergocristinine and vascular receptors
Toxicology Reports,
Journal Year:
2023,
Volume and Issue:
10, P. 604 - 611
Published: Jan. 1, 2023
Ergot
alkaloids
are
secondary
metabolites
that
exist
in
two
configurations,
the
C-8-R-isomer
(R-epimer),
and
C-8-S-isomer
(S-epimer).
Toxic
effects
of
ergot,
such
as
vasoconstriction,
have
been
primarily
attributed
to
R-epimer
bioactivity,
compared
S-epimer.
Recent
studies
demonstrated
potential
bioactivity
S-epimers.
Therefore,
further
cost-effective
investigations
S-epimers
needed.
The
present
study
investigated
S-epimer
-
vascular
receptor
binding
relationship.
An
silico
molecular
docking
approach,
utilizing
AutoDock
Vina
DockThor,
was
used
determine
if
(ergocristinine)
binds
receptors
compare
affinity
interactions
corresponding
(ergocristine)
a
structural
analogue
(lysergic
acid
amide).
energy
(kcal/mol)
ergocristinine
9.7
or
11.0
serotonin
(5-HT)
2
A
8.7
11.4
alpha
adrenergic
receptor,
depending
on
software
used.
hydrogen
bond
formed
between
amino
residues
5-HT
sites,
with
lengths
3.10
Å
3.28
Å,
respectively.
Binding
affinities
among
ligands
each
differed.
Different
may
relate
differences
chemical
structures.
strong
contribute
observed
physiological
manifestations
occur
after
ergot
alkaloid
exposure.
results
suggest
investigation
alkaloids.
Language: Английский